These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17048295)

  • 1. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1.
    Daum S; Erdmann F; Fischer G; Féaux de Lacroix B; Hessamian-Alinejad A; Houben S; Frank W; Braun M
    Angew Chem Int Ed Engl; 2006 Nov; 45(44):7454-8. PubMed ID: 17048295
    [No Abstract]   [Full Text] [Related]  

  • 2. Aryl hetaryl ketones and thioketones as efficient inhibitors of peptidyl-prolyl cis-trans isomerases.
    Hediger T; Frank W; Schumann M; Fischer G; Braun M
    Chem Biodivers; 2012 Nov; 9(11):2618-34. PubMed ID: 23161639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent synthesis of alpha-ketoamide inhibitors of Pin1.
    Xu GG; Etzkorn FA
    Org Lett; 2010 Feb; 12(4):696-9. PubMed ID: 20102178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
    Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
    J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pin1: a multi-talented peptidyl prolyl cis-trans isomerase and a promising therapeutic target for human cancers].
    Marsolier J; Weitzman JB
    Med Sci (Paris); 2014; 30(8-9):772-8. PubMed ID: 25174754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of novel human Pin1 inhibitors (I).
    Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
    Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
    Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ; Zhang ZH; Xu BL; Wang YL
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformation-directed catalysis and coupled enzyme-substrate dynamics in Pin1 phosphorylation-dependent cis-trans isomerase.
    Velazquez HA; Hamelberg D
    J Phys Chem B; 2013 Oct; 117(39):11509-17. PubMed ID: 23980573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel spiroannulated 3-benzofuranones. Synthesis and inhibition of the human peptidyl prolyl cis/trans isomerase Pin1.
    Braun M; Hessamian-Alinejad A; de Lacroix BF; Alvarez BH; Fischer G
    Molecules; 2008 Apr; 13(4):995-1003. PubMed ID: 18463601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1.
    Jiang B; Pei D
    J Med Chem; 2015 Aug; 58(15):6306-12. PubMed ID: 26196061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptidyl prolyl isomerase Pin1-inhibitory activity of D-glutamic and D-aspartic acid derivatives bearing a cyclic aliphatic amine moiety.
    Nakagawa H; Seike S; Sugimoto M; Ieda N; Kawaguchi M; Suzuki T; Miyata N
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5619-24. PubMed ID: 26508545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prolyl isomerase pin1 in pathogenesis of diseases and remedy for the diseases from natural products.
    Takahashi K; Shimizu T; Kosaka K; Hidaka M; Uchida C; Uchida T
    Curr Drug Targets; 2014; 15(10):973-81. PubMed ID: 25182609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
    Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
    J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
    Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
    Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate-based design of reversible Pin1 inhibitors.
    Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
    Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peptidyl-prolyl isomerase Pin1.
    Joseph JD; Yeh ES; Swenson KI; Means AR; Winkler
    Prog Cell Cycle Res; 2003; 5():477-87. PubMed ID: 14593743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1.
    Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C
    Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for high-affinity peptide inhibition of human Pin1.
    Zhang Y; Daum S; Wildemann D; Zhou XZ; Verdecia MA; Bowman ME; Lücke C; Hunter T; Lu KP; Fischer G; Noel JP
    ACS Chem Biol; 2007 May; 2(5):320-8. PubMed ID: 17518432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
    Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
    Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.